RLMD

Relmada Therapeutics Inc

May 19 • 01:36PM ET

6.89

+0.55 8.75 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NMRA AXSM SUPN ACAD PRTA

| Held by: VTI VXF PSIL ITOT ONEQ PRFZ IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	12.25%	Shs Outstand	104.89M	Perf Week	-7.45%
Market Cap	723.21M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.31%	Shs Float	99.24M	Perf Month	-6.45%
Enterprise Value	489.25M	PEG	-	EPS next Q	-0.19	Inst Own	70.60%	Short Float	5.39%	Perf Quarter	69.00%
Income	-58.88M	P/S	-	EPS this Y	44.83%	Inst Trans	42.86%	Short Ratio	2.84	Perf Half Y	74.56%
Sales	0.00M	P/B	3.31	EPS next Y	-19.75%	ROA	-44.77%	Short Interest	5.35M	Perf YTD	42.75%
Book/sh	2.09	P/C	3.09	EPS next 5Y	12.24%	ROE	-48.83%	52W High	8.00 -13.81%	Perf Year	1254.62%
Cash/sh	2.23	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-26.92%	52W Low	0.44 1483.60%	Perf 3Y	117.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.26% 6.56%	Perf 5Y	-80.69%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	55.59%	Oper. Margin	-	ATR (14)	0.50	Perf 10Y	-36.86%
Dividend Ex-Date	-	Quick Ratio	18.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.74	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.26	EPS Q/Q	61.90%	SMA20	-5.25%	Beta	0.39	Target Price	12.80
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-0.65%	Rel Volume	0.64	Prev Close	6.34
Employees	17	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	73.24%	Avg Volume	1.88M	Price	6.89
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.84% -	Trades		Volume	784,696	Change	8.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)